Becton Dickinson (BDX) stock: analyst price target and their real reliability
Live quote · data updated Oct 14, 2026
Becton Dickinson · Health Care · ref. ETF XLV · 50 calls · price $187.37
What the company does: Operating globally, Becton, Dickinson and Company (BD) is a prominent enterprise focused on the development, manufacturing, and distribution of a broad spectrum of medical technology.
📈 Becton Dickinson (BDX) stock price
$187.37+26.5% over range
Oct 14, 25low $138.67 · high $192Oct 13, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Hold
33% recommend buying · 9 analysts
📊 JPI status : Becton Dickinson has never appeared in a JPI ranking (Fair or Risk +) — our methods haven't picked it to date. See the selected stocks →
⚠️ The stock trades above the median target: it has beaten expectations. The “Hold” reflects conviction on the company, but the remaining quantified upside is low/negative.
🎯 BDX price target & analyst consensus — price $187
The price target · all analysts combined (9 targets)
Highest target · 1 firm of 9$204+8.9%
Median target · of 9 targets$182-2.9%
Lowest target · 1 firm of 9$165-11.9%
Current price$187.37
Where these 9 targets sit · versus the current price · 1 target per firm, last 6 months
Above the price
444%
$190 ↔ $204
Below
556%
$165 ↔ $182
⭐ What the most reliable analysts say
· those who beat their sector, targets replayed on real prices
⭐ The most reliable of them, either direction: B of A Securities — 68% of its targets hit on this sector (362 calls tested). It aims for $200 (+6.7 %), call made on September 1, 2026, maturing on September 1, 2027 (43 d ago).
The 7 reliable analysts
$182-2.9 %
The 2 other firms
$185-1.3 %
How to read it: the 7 reliable firms are not filtered by optimism — 3 aim above the price, 4 below, hence their $182 median. “The 2 others” are the firms that don't pass our reliability filter on this sector.
The consensus · 9 ratings (last 6 months)
Strong Buy00%
Buy333%
Hold556%
Sell111%
Strong Sell00%
Go deeper on the analysts
🎯 BDX price target all
All 50 calls, one by one, with our verdict on each firm.
→ See all 50 targets, analyst by analyst💡 The best analysts on BDX most reliable
The case for and against, with the numbers, per those who've been right on the stock.
→ Should you invest in BDX? The case for & againstAll analysts (the consensus) · vs · the best (those who've been right)
💬 A question about Becton Dickinson? The JPI assistant answers using our backtest data.
💰 Becton Dickinson dividend: yield, history & growth › open the full page
2.45%annual yield
🏆 Aristocrat — 28 yrs of consecutive dividend increases
That's ~$3.74 per share per year.
📈 Becton Dickinson fundamentals: valuation, margins & growth › open the full page
P/E 43.6Net margin 4.2 %Revenue growth +5.4 %High P/E
Revenue, net income and margin per year
Revenue Net income · hover a bar for details
2022
marg. 9 %
2023
Rev +3%Profit −16%
2024
Rev +5%Profit +21%
2025
Rev +8%Profit −3%
🔎 Detailed analyses
✅ Historical analyst reliability on BDX
Hit rate measured on targets already matured (12 months), replayed against real prices. Click a header to sort.
| Firm ↕ | % right i ↕ | Gain vs sector i ↕ | Calls i ↕ |
|---|---|---|---|
| ISI Group | 100% | +21.7% | 2 |
| Deutsche Bank ↗ | 100% | +20.8% | 2 |
| Jefferies ↗ | 100% | +18.3% | 3 |
| UBS ↗ | 100% | +14.9% | 2 |
| Citigroup ↗ | 62% | +2.3% | 8 |
| Wells Fargo ↗ | 57% | +4.5% | 7 |
| Stifel ↗ | 57% | -1.0% | 7 |
| JP Morgan ↗ | 57% | -6.7% | 7 |
| Goldman Sachs ↗ | 50% | -5.6% | 4 |
| Morgan Stanley ↗ | 43% | +1.1% | 14 |
See the other 5 firms
| Piper Sandler ↗ | 14% | -6.0% | 7 |
| Evercore ISI Group ↗ | 20% | -4.2% | 5 |
| Barclays ↗ | 31% | -8.8% | 13 |
| Keybanc ↗ | 33% | +0.1% | 6 |
| Raymond James ↗ | 38% | -0.8% | 16 |
📊 What $1,000 invested in Becton Dickinson would be worth › open the full page
In short — $1,000 invested in Becton Dickinson 10 years ago would be worth $1,357 today, i.e. +3%/yr on average. Best year: 2017 (+37%), worst: 2025 (-18%). Price performance, excluding dividends.
If I'd invested $1,000 in Becton Dickinson
| Investment | Worth today | Gain |
|---|---|---|
| 1 years ago | $777 | -22% |
| 3 years ago | $763 | -24% |
| 5 years ago | $754 | -25% |
Return by year (Becton Dickinson)
| Year | Return | $1,000 invested at year start |
|---|---|---|
| 2026 (YTD) | -5% | $946 (-5%) |
| 2025 | -18% | $777 (-22%) |
| 2024 | +4% | $806 (-19%) |
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.
📰 Recent news on Becton Dickinson
Loading news…
📋 All analyst calls on BDX
Filtered on — · ✕ show all
▼ Underweight · 🎯$165
Price at call : $182.75 — upside -10%
Today : $187.37 — upside -12%
🎯 on BDX : 50% (4 calls matureds) · 📊 on Health : 50.1% · +2.0% (645 calls)
in progress (365j)
matures : Oct 7, 27
matures : Oct 7, 27
B of A Securities ↗
Aug 31, 26
■ Neutral neutral · not a buy · 🎯$200
Price at call : $187.12 — gap to target +7%
Today : $187.37 — gap to target +7%
🎯 on BDX : no call matured yet · 📊 on Health : 48.1% · +2.0% (362 calls)
in progress (365j)
matures : Aug 31, 27
matures : Aug 31, 27
RBC Capital ↗
Aug 13, 26
■ Sector Perform neutral · not a buy · 🎯$190
Price at call : $183.4 — gap to target +4%
Today : $187.37 — gap to target +1%
🎯 on BDX : no call matured yet · 📊 on Health : 42.8% · -2.5% (397 calls)
in progress (365j)
matures : Aug 13, 27
matures : Aug 13, 27
▲ Buy · 🎯$204
Price at call : $179.63 — upside +14%
Today : $187.37 — upside +9%
🎯 on BDX : 50% (2 calls matureds) · 📊 on Health : 53.1% · +2.4% (516 calls)
in progress (365j)
matures : Aug 7, 27
matures : Aug 7, 27
RBC Capital ↗
Aug 7, 26
■ Sector Perform neutral · not a buy · 🎯$180
Price at call : $179.63 — gap to target +0%
Today : $187.37 — gap to target -4%
🎯 on BDX : no call matured yet · 📊 on Health : 42.8% · -2.5% (397 calls)
in progress (365j)
matures : Aug 7, 27
matures : Aug 7, 27
Piper Sandler ↗
Aug 7, 26
■ Neutral neutral · not a buy · 🎯$175
Price at call : $179.63 — gap to target -3%
Today : $187.37 — gap to target -7%
🎯 on BDX : 0% (2 calls matureds) · 📊 on Health : 46.6% · -1.4% (324 calls)
in progress (365j)
matures : Aug 7, 27
matures : Aug 7, 27
Wells Fargo ↗
Aug 7, 26
■ Equal-Weight neutral · not a buy · 🎯$170
Price at call : $179.63 — gap to target -5%
Today : $187.37 — gap to target -9%
🎯 on BDX : no call matured yet · 📊 on Health : 47.6% · +1.0% (403 calls)
in progress (365j)
matures : Aug 7, 27
matures : Aug 7, 27
■ Hold neutral · not a buy · 🎯$182
Price at call : $177.07 — gap to target +3%
Today : $187.37 — gap to target -3%
🎯 on BDX : no call matured yet · 📊 on Health : 48% · +0.6% (98 calls)
in progress (365j)
matures : Aug 5, 27
matures : Aug 5, 27
See the other 42 calls, newest to oldest
▲ Buy · 🎯$190
Price at call : $168.4 — upside +13%
Today : $187.37 — upside +1%
🎯 on BDX : no call matured yet · 📊 on Health : 51.7% · +3.1% (358 calls)
in progress (365j)
matures : Jul 28, 27
matures : Jul 28, 27
Evercore ISI Group ↗
Jul 6, 26
▲ Outperform · 🎯$180
Price at call : $156.3 — upside +15%
Today : $187.37 — upside -4%
🎯 on BDX : 0% (1 call matured) · 📊 on Health : 44.6% · -0.4% (186 calls)
in progress (365j)
matures : Jul 6, 27
matures : Jul 6, 27
▲ Overweight · 🎯$204
Price at call : $143.15 — upside +43%
Today : $187.37 — upside +9%
🎯 on BDX : 50% (4 calls matureds) · 📊 on Health : 50.1% · +2.0% (645 calls)
in progress (365j)
matures : May 11, 27
matures : May 11, 27
Wells Fargo ↗
May 8, 26
■ Equal-Weight neutral · not a buy · 🎯$161
Price at call : $149.43 — gap to target +8%
Today : $187.37 — gap to target -14%
🎯 on BDX : no call matured yet · 📊 on Health : 47.6% · +1.0% (403 calls)
in progress (365j)
matures : May 8, 27
matures : May 8, 27
■ Hold neutral · not a buy · 🎯$163
Price at call : $144.17 — gap to target +13%
Today : $187.37 — gap to target -13%
🎯 on BDX : no call matured yet · 📊 on Health : 48% · +0.6% (98 calls)
in progress (365j)
matures : May 4, 27
matures : May 4, 27
Piper Sandler ↗
Apr 17, 26
■ Neutral neutral · not a buy · 🎯$159
Price at call : $158.64 — gap to target +0%
Today : $187.37 — gap to target -15%
🎯 on BDX : 0% (2 calls matureds) · 📊 on Health : 46.6% · -1.4% (324 calls)
in progress (365j)
matures : Apr 17, 27
matures : Apr 17, 27
Argus Research ↗
Mar 23, 26
▲ Buy · 🎯$180
Price at call : $155.92 — upside +15%
Today : $187.37 — upside -4%
🎯 on BDX : no call matured yet · 📊 on Health : 55.3% · +2.1% (159 calls)
in progress (365j)
matures : Mar 23, 27
matures : Mar 23, 27
▲ Buy · 🎯$198
Price at call : $177.81 — upside +11%
Today : $187.37 — upside +6%
🎯 on BDX : 50% (2 calls matureds) · 📊 on Health : 53.1% · +2.4% (516 calls)
in progress (365j)
matures : Feb 11, 27
matures : Feb 11, 27
■ Neutral neutral · not a buy · 🎯$175
Price at call : $180.62 — gap to target -3%
Today : $187.37 — gap to target -7%
🎯 on BDX : no call matured yet · 📊 on Health : 53.8% · +5.2% (364 calls)
in progress (365j)
matures : Feb 10, 27
matures : Feb 10, 27
▲ Buy · 🎯$190
Price at call : $180.62 — upside +5%
Today : $187.37 — upside +1%
🎯 on BDX : no call matured yet · 📊 on Health : 51.2% · +4.7% (383 calls)
in progress (365j)
matures : Feb 10, 27
matures : Feb 10, 27
RBC Capital ↗
Feb 10, 26
■ Sector Perform neutral · not a buy · 🎯$172
Price at call : $180.62 — gap to target -5%
Today : $187.37 — gap to target -8%
🎯 on BDX : no call matured yet · 📊 on Health : 42.8% · -2.5% (397 calls)
in progress (365j)
matures : Feb 10, 27
matures : Feb 10, 27
▲ Buy · 🎯$232
Price at call : $180.62 — upside +28%
Today : $187.37 — upside +24%
🎯 on BDX : 50% (2 calls matureds) · 📊 on Health : 53.1% · +2.4% (516 calls)
in progress (365j)
matures : Feb 10, 27
matures : Feb 10, 27
Piper Sandler ↗
Feb 10, 26
■ Neutral neutral · not a buy · 🎯$170
Price at call : $180.62 — gap to target -6%
Today : $187.37 — gap to target -9%
🎯 on BDX : 0% (2 calls matureds) · 📊 on Health : 46.6% · -1.4% (324 calls)
in progress (365j)
matures : Feb 10, 27
matures : Feb 10, 27
Wells Fargo ↗
Feb 10, 26
■ Equal-Weight neutral · not a buy · 🎯$123.4277
Price at call : $171.68 — gap to target -28%
Today : $187.37 — gap to target -34%
🎯 on BDX : no call matured yet · 📊 on Health : 47.6% · +1.0% (403 calls)
in progress (365j)
matures : Feb 10, 27
matures : Feb 10, 27
Piper Sandler ↗
Jan 28, 26
■ Neutral neutral · not a buy · 🎯$161.1635
Price at call : $158.74 — gap to target +2%
Today : $187.37 — gap to target -14%
🎯 on BDX : 0% (2 calls matureds) · 📊 on Health : 46.6% · -1.4% (324 calls)
in progress (365j)
matures : Jan 28, 27
matures : Jan 28, 27
▲ Buy · 🎯$169.0252
Price at call : $159.36 — upside +6%
Today : $187.37 — upside -10%
🎯 on BDX : 50% (2 calls matureds) · 📊 on Health : 50.7% · +7.8% (304 calls)
in progress (365j)
matures : Jan 7, 27
matures : Jan 7, 27
B of A Securities ↗
Jan 5, 26
■ Neutral neutral · not a buy · 🎯$162.7358
Price at call : $156.42 — gap to target +4%
Today : $187.37 — gap to target -13%
🎯 on BDX : no call matured yet · 📊 on Health : 48.1% · +2.0% (362 calls)
in progress (365j)
matures : Jan 5, 27
matures : Jan 5, 27
RBC Capital ↗
Dec 17, 25
■ Sector Perform neutral · not a buy · 🎯$165.0943
Price at call : $153.58 — gap to target +7%
Today : $187.37 — gap to target -12%
🎯 on BDX : no call matured yet · 📊 on Health : 42.8% · -2.5% (397 calls)
in progress (365j)
matures : Dec 17, 26
matures : Dec 17, 26
Morgan Stanley ↗
Dec 2, 25
▲ Overweight · 🎯$165.0943
Price at call : $152.18 — upside +8%
Today : $187.37 — upside -12%
🎯 on BDX : 100% (2 calls matureds) · 📊 on Health : 51.6% · +5.2% (830 calls)
in progress (365j)
matures : Dec 2, 26
matures : Dec 2, 26
RBC Capital ↗
Nov 7, 25
■ Sector Perform neutral · not a buy · 🎯$158.805
Price at call : $142.8 — gap to target +11%
Today : $187.37 — gap to target -15%
🎯 on BDX : no call matured yet · 📊 on Health : 42.8% · -2.5% (397 calls)
in progress (365j)
matures : Nov 7, 26
matures : Nov 7, 26
Piper Sandler ↗
Nov 7, 25
■ Neutral neutral · not a buy · 🎯$149.3711
Price at call : $139.81 — gap to target +7%
Today : $187.37 — gap to target -20%
🎯 on BDX : 0% (2 calls matureds) · 📊 on Health : 46.6% · -1.4% (324 calls)
in progress (365j)
matures : Nov 7, 26
matures : Nov 7, 26
RBC Capital ↗
Oct 16, 25
■ Sector Perform neutral · not a buy · 🎯$165.8805
Price at call : $148.66 — gap to target +12%
Today : $187.37 — gap to target -11%
🎯 on BDX : no call matured yet · 📊 on Health : 42.8% · -2.5% (397 calls)
in progress (365j)
matures : Oct 16, 26
matures : Oct 16, 26
RBC Capital ↗
Sep 25, 25
■ Sector Perform neutral · not a buy · 🎯$165.8805
Price at call : $141.97 — gap to target +17%
Today : $187.37 — gap to target -11%
🎯 on BDX : no call matured yet · 📊 on Health : 42.8% · -2.5% (397 calls)
in progress (365j)
matures : Sep 25, 26
matures : Sep 25, 26
Morgan Stanley ↗
Aug 11, 25
▲ Overweight · 🎯$154.8742
Price at call : $153.27 — upside +1%
Today : $187.37 — upside -17%
Expected +1% · Actual +20% · Reason (≥ +15%) : ✓ Yes
🎯 on BDX : 100% (2 calls matureds) · 📊 on Health : 51.6% · +5.2% (830 calls)
+19.8%
stock +20% · XLV +28%
matured Aug 11, 26
Wells Fargo ↗
Aug 8, 25
■ Equal-Weight neutral · not a buy · 🎯$144.6541
Price at call : $151.34 — gap to target -4%
Today : $187.37 — gap to target -23%
🎯 on BDX : no call matured yet · 📊 on Health : 47.6% · +1.0% (403 calls)
in progress (365j)
matures : Aug 8, 26
matures : Aug 8, 26
Piper Sandler ↗
Aug 8, 25
■ Neutral neutral · not a buy · 🎯$157.2327
Price at call : $152.12 — gap to target +3%
Today : $187.37 — gap to target -16%
🎯 on BDX : 0% (2 calls matureds) · 📊 on Health : 46.6% · -1.4% (324 calls)
in progress (365j)
matures : Aug 8, 26
matures : Aug 8, 26
▲ Overweight · 🎯$189.4654
Price at call : $134.17 — upside +41%
Today : $187.37 — upside +1%
Expected +41% · Actual +9% · Reason (≥ +15%) : ✗ No
🎯 on BDX : 50% (4 calls matureds) · 📊 on Health : 50.1% · +2.0% (645 calls)
+8.5%
stock +9% · XLV +11%
matured Jun 3, 26
■ Neutral neutral · not a buy · 🎯$145.4403
Price at call : $135.46 — gap to target +7%
Today : $187.37 — gap to target -22%
🎯 on BDX : 50% (2 calls matureds) · 📊 on Health : 53.1% · +2.4% (516 calls)
in progress (365j)
matures : May 22, 26
matures : May 22, 26
Morgan Stanley ↗
May 6, 25
▲ Overweight · 🎯$154.0881
Price at call : $131.4 — upside +17%
Today : $187.37 — upside -18%
Expected +17% · Actual +17% · Reason (≥ +15%) : ✓ Yes
🎯 on BDX : 100% (2 calls matureds) · 📊 on Health : 51.6% · +5.2% (830 calls)
+16.6%
stock +17% · XLV +7%
matured May 6, 26
Piper Sandler ↗
May 2, 25
■ Neutral neutral · not a buy · 🎯$145.4403
Price at call : $131.29 — gap to target +11%
Today : $187.37 — gap to target -22%
🎯 on BDX : 0% (2 calls matureds) · 📊 on Health : 46.6% · -1.4% (324 calls)
in progress (365j)
matures : May 2, 26
matures : May 2, 26
▲ Buy · 🎯$176.1006
Price at call : $131.29 — upside +34%
Today : $187.37 — upside -6%
Expected +34% · Actual +11% · Reason (≥ +15%) : ✗ No
🎯 on BDX : 50% (2 calls matureds) · 📊 on Health : 50.7% · +7.8% (304 calls)
+11.4%
stock +11% · XLV +5%
matured May 2, 26
William Blair ↗
May 2, 25
■ Market Perform neutral · not a buy
🎯 on BDX : no call matured yet · 📊 on Health : 64.3% · +7.1% (28 calls)
in progress (365j)
matures : May 2, 26
matures : May 2, 26
▲ Buy · 🎯$170.5975
Price at call : $132.69 — upside +29%
Today : $187.37 — upside -9%
Expected +29% · Actual +10% · Reason (≥ +15%) : ✗ No
🎯 on BDX : 50% (2 calls matureds) · 📊 on Health : 53.1% · +2.4% (516 calls)
+10.3%
stock +10% · XLV +4%
matured May 1, 26
Piper Sandler ↗
Apr 23, 25
▲ Overweight · 🎯$204.4025
Price at call : $160.73 — upside +27%
Today : $187.37 — upside +9%
Expected +27% · Actual -5% · Reason (≥ +15%) : ✗ No
🎯 on BDX : 0% (2 calls matureds) · 📊 on Health : 46.6% · -1.4% (324 calls)
-5.3%
stock -5% · XLV +5%
matured Apr 23, 26
▲ Overweight · 🎯$205.1887
Price at call : $157.89 — upside +30%
Today : $187.37 — upside +10%
Expected +30% · Actual -1% · Reason (≥ +15%) : ✗ No
🎯 on BDX : 50% (4 calls matureds) · 📊 on Health : 50.1% · +2.0% (645 calls)
-0.5%
stock -1% · XLV +13%
matured Apr 7, 26
▲ Overweight · 🎯$219.3396
Price at call : $176.73 — upside +24%
Today : $187.37 — upside +17%
Expected +24% · Actual +0% · Reason (≥ +15%) : ✗ No
🎯 on BDX : 50% (4 calls matureds) · 📊 on Health : 50.1% · +2.0% (645 calls)
+0.4%
stock +0% · XLV +9%
matured Feb 14, 26
Piper Sandler ↗
Jan 28, 25
▲ Overweight · 🎯$220.1258
Price at call : $195.82 — upside +12%
Today : $187.37 — upside +17%
Expected +12% · Actual -19% · Reason (≥ +15%) : ✗ No
🎯 on BDX : 0% (2 calls matureds) · 📊 on Health : 46.6% · -1.4% (324 calls)
-18.9%
stock -19% · XLV +5%
matured Jan 28, 26
▲ Overweight · 🎯$218.5535
Price at call : $187.04 — upside +17%
Today : $187.37 — upside +17%
Expected +17% · Actual -13% · Reason (≥ +15%) : ✗ No
🎯 on BDX : 50% (4 calls matureds) · 📊 on Health : 50.1% · +2.0% (645 calls)
-13.4%
stock -13% · XLV +11%
matured Jan 22, 26
Evercore ISI Group ↗
Oct 1, 24
▲ Outperform · 🎯$227.9874
Price at call : $188.49 — upside +21%
Today : $187.37 — upside +22%
Expected +21% · Actual -20% · Reason (≥ +15%) : ✗ No
🎯 on BDX : 0% (1 call matured) · 📊 on Health : 44.6% · -0.4% (186 calls)
-20.1%
stock -20% · XLV -6%
matured Oct 1, 25
▲ Buy · 🎯$216.195
Price at call : $188.49 — upside +15%
Today : $187.37 — upside +15%
Expected +15% · Actual -20% · Reason (≥ +15%) : ✗ No
🎯 on BDX : 50% (2 calls matureds) · 📊 on Health : 53.1% · +2.4% (516 calls)
-20.1%
stock -20% · XLV -6%
matured Oct 1, 25
Raymond James ↗
Aug 2, 24
▲ Outperform · 🎯$212.2642
Price at call : $185.36 — upside +15%
Today : $187.37 — upside +13%
Expected +15% · Actual -24% · Reason (≥ +15%) : ✗ No
🎯 on BDX : 0% (1 call matured) · 📊 on Health : 46.4% · +1.6% (403 calls)
-24.1%
stock -24% · XLV -9%
matured Aug 2, 25
Frequently asked questions
Should I buy Becton Dickinson stock?
This isn't buy advice. For Becton Dickinson, the analyst consensus is "Hold", with an average price target of $182 (-3% vs the current price). What matters is their past reliability on this stock: the most reliable one is right 100% of the time (2 calls tracked on Becton Dickinson). We show the numbers — you decide.
Is it too late to buy Becton Dickinson? How high can it go?
The most bullish analyst target on Becton Dickinson is $204 (+9% above today's price); the average is $182. That's the upside they see. Check how reliable those analysts have actually been on Becton Dickinson on our site before trusting it.
Is Becton Dickinson still a good buy?
The most useful "opinion" isn't an opinion — it's a track record: 15 analysts have a real record on Becton Dickinson, the best hitting 100% over 2 calls. Current consensus: "Hold". Make your call on data, not noise.
Should you invest in Becton Dickinson? The case for and against
The arguments for and against, one by one, from the numbers: why invest in BDX (and why hesitate).
What has Becton Dickinson's past performance been?
Historical returns and a "how much if I had invested" calculator: BDX performance & returns.
Does Becton Dickinson pay a dividend?
Yield, consistency and growth history of the dividend: BDX's dividend.
BIIB 
VRTX 
REGN 
UNH 
EW 
SRPT 
VEEV 
BSX